menu Search
Sybrava

Sybrava Overdosage

inclisiran

Manufacturer:

Novartis Pharmaceutical Manufacturing GmbH

Distributor:

Novartis Healthcare
Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing
Full Prescribing Info
Overdosage
No clinically relevant adverse effects were observed in healthy volunteers who received inclisiran at doses up to three times the therapeutic dose. No specific treatment for inclisiran (Sybrava) overdose is available. In the event of an overdose, the patient should be treated symptomatically, and supportive measures instituted as required.